GlassScriptPhysician profile
Juan M Prati
NPI 1851445092
$5,014.08
in general payments reported to CMS, 2019-2025
20 companies · $937 in 2025
The $937 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $16.69 · 2021: $325 · 2022: $678 · 2023: $384 · 2024: $2,186 · 2025: $937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,977 · Entertainment: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,977.29 |
| Entertainment | $530.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $1,334.16 | 2024 | |
| Alcon Vision LLC | $1,089.11 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Optos, INC. | $799.74 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $266.14 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $242.58 | 2024-2025 | |
| Lkc Technologies, INC. | $195.48 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $152.98 | 2019 | |
| Biotissue Holdings INC. | $138.50 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $121.86 | 2025 | Ultomiris |
| Maculogix, INC. | $113.73 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $107.90 | 2022-2025 | Infuse |
| Harrow Eye, LLC | $98.55 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $94.25 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $76.65 | 2022 | |
| Genzyme Corporation | $48.74 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $42.95 | 2019-2022 | |
| Abbvie INC. | $29.50 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.30 | 2022 | |
| Oyster Point Pharma, INC. | $21.27 | 2022 | |
| Sight Sciences, INC. | $16.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Prati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.